Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in Stage I lung adenocarcinoma

Yoshio Tomizawa, Takashi Kohno, Haruhiko Kondo, Ayaka Otsuka, Michiho Nishioka, Toshiro Niki, Tesshi Yamada, Arafumi Maeshima, Kimio Yoshimura, Ryusei Saito, John D. Minna, Jun Yokota

Research output: Contribution to journalArticlepeer-review

127 Scopus citations

Fingerprint

Dive into the research topics of 'Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in Stage I lung adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences